Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
JAMA: Journal of the American Medical Association; 11/26/2008, Vol. 300 Issue 20, p2389-2397, 9p
Record details
-
Authors :
Peng R; Department of Ophthalmology, Peking University Third Hospital, Beijing, China.; Key Laboratory of Vision Loss and Restoration, Ministry of Education, Beijing, China.
Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use ; Dry Eye Syndromes*; Adult
-
Source:
JAMA ophthalmology [JAMA Ophthalmol] 2024 Apr 01; Vol. 142 (4), pp. 337-343.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print
Record details
-
Authors :
Wang L; Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Wang W
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology
-
Source:
JAMA oncology [JAMA Oncol] 2024 Feb 01; Vol. 10 (2), pp. 256-258.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print
Record details
-
Authors :
Mai HQ; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou.; Chen QY
Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use
-
Source:
JAMA [JAMA] 2023 Nov 28; Vol. 330 (20), pp. 1961-1970.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited
Record details
-
Authors :
Wang L; Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Berger NA
Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology; Antibodies, Viral ; Child SARS-CoV-2 variants
-
Source:
JAMA pediatrics [JAMA Pediatr] 2022 Aug 01; Vol. 176 (8), pp. 811-813.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print
Record details
-
Authors :
Wang W; Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Center for Science, Health, and Society, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Colorectal Neoplasms*; Aged
-
Source:
JAMA oncology [JAMA Oncol] 2022 Jul 01; Vol. 8 (7), pp. 1027-1034.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print
Record details
-
Authors :
Wang L; Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Davis PB
Subjects: 2019-nCoV Vaccine mRNA-1273* ; BNT162 Vaccine* ; SARS-CoV-2*COVID-19 breakthrough infectionsSARS-CoV-2 variants
-
Source:
JAMA [JAMA] 2022 Feb 15; Vol. 327 (7), pp. 678-680.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited
Record details
-
Authors :
Wang L; Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Center for Science, Health, and Society, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Subjects: COVID-19/COVID-19/COVID-19/*epidemiology ; Hospitalization/Hospitalization/Hospitalization/*statistics & numerical data ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*epidemiology COVID-19 breakthrough infections
-
Source:
JAMA network open [JAMA Netw Open] 2021 Nov 01; Vol. 4 (11), pp. e2137575. Date of Electronic Publication: 2021 Nov 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic
Record details
-
Authors :
Xu R; Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Subjects: COVID-19* ; Neoplasms*/Neoplasms*/Neoplasms*/epidemiology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy
-
Source:
JAMA oncology [JAMA Oncol] 2021 Jul 01; Vol. 7 (7), pp. 1065-1066.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print
Record details
-
Authors :
Jan C; Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China.; The George Institute for Global Health, School of Medicine, The University of New South Wales, Sydney, New South Wales, Australia.
Subjects: Population Surveillance* ; Schools* ; Students*
-
Source:
JAMA pediatrics [JAMA Pediatr] 2019 Jul 01; Vol. 173 (7), pp. e190914. Date of Electronic Publication: 2019 Jul 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model:
Record details
-
Authors :
Chow CHT; Department of Psychology, Neuroscience, and Behaviour, McMaster University, Hamilton, Ontario, Canada.; Rizwan A
Subjects: Anxiety* ; Temperament*; Anesthesia, General/Anesthesia, General/Anesthesia, General/*psychology
-
Source:
JAMA network open [JAMA Netw Open] 2019 Jun 05; Vol. 2 (6), pp. e195614. Date of Electronic Publication: 2019 Jun 05.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic
Record details